Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

Autor: Stone, Richard M., DeAngelo, Daniel J., Klimek, Virginia, Galinsky, Ilene, Estey, Eli, Nimer, Stephen D., Grandin, Wilson, Lebwohl, David, Wang, Yanfeng, Cohen, Pamela, Fox, Edward A., Neuberg, Donna, Clark, Jennifer, Gilliland, D. Gary, Griffin, James D.
Zdroj: In Blood 1 January 2005 105(1):54-60
Databáze: ScienceDirect